IL-6 overexpression in ERG-positive prostate cancer is mediated by prostaglandin receptor EP2

Constanze Merz, Anne Von Mässenhausen, Angela Queisser, Wenzel Vogel, Ove Andrén, Jutta Kirfel, Stefan Duensing, Sven Perner, Michael Nowak*

*Corresponding author for this work
10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'IL-6 overexpression in ERG-positive prostate cancer is mediated by prostaglandin receptor EP2'. Together they form a unique fingerprint.

Medicine & Life Sciences